Chlorozotocin

Chlorozotocin is a nitrosourea. It is used for cancer therapy.

Chlorozotocin

Clinical data
ATC code	none
Identifiers
IUPAC name 2-{[(2-Chloroethyl)(nitroso)carbamoyl]amino}-2-deoxy-D-glucose
CAS Number	54749-90-5
PubChem CID	451706
ChemSpider	397854
UNII	3053LTY75Z
KEGG	C19170
ChEMBL	ChEMBL2094020
CompTox Dashboard (EPA)	DTXSID9020320
Chemical and physical data
Formula	C9H16ClN3O7
Molar mass	313.69 g·mol^−1
3D model (JSmol)	Interactive image
SMILES ClCCN(N=O)C(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO
InChI InChI=1S/C9H16ClN3O7/c10-1-2-13(12-20)9(19)11-5(3-14)7(17)8(18)6(16)4-15/h3,5-8,15-18H,1-2,4H2,(H,11,19)/t5-,6+,7+,8+/m0/s1 Key:MKQWTWSXVILIKJ-LXGUWJNJSA-N
(what is this?)  (verify)

The International Agency for Research on Cancer concluded it was "probably carcinogenic" in 1990[1]

It is an analogue of streptozotocin.[2]

References

1. Humans, IARC Working Group on the Evaluation of Carcinogenic Risk to (1990). SUMMARY OF FINAL EVALUATIONS. International Agency for Research on Cancer.
2. Wolfe MM (2006). Therapy of digestive disorders. Elsevier Health Sciences. p. 477. ISBN 978-1-4160-0317-5.